Leuprorelin EP Impurity J arises from subtle synthetic or oxidative modifications within the leuprorelin backbone. Structural variance impacts retention behavior and peptide conformation. Researchers employ it to refine impurity methods and stability guidance. Applications include analytical validation, impurity profiling, and synthetic-route optimization.
CAT No: Z10-101-173
Synonyms/Alias:[8-[5-N-[Imino(1H-pyrazol-1-yl)methyl]-L-ornithine]]leuprorelin; Leuprorelin Impurity J; (2S)-1-((3S,6S,9S,12S,15R,18S)-3-((1H-imidazol-4-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-(1H-pyrazole-1-carboximidamido)propyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide
Leuprorelin (Leuprolide) EP Impurity J is a structurally defined peptide impurity associated with the synthesis and quality assessment of leuprorelin, a well-known gonadotropin-releasing hormone (GnRH) analog. As a reference impurity, Leuprorelin (Leuprolide) EP Impurity J plays a crucial role in pharmaceutical and analytical research, enabling scientists to evaluate the purity, stability, and degradation profiles of leuprorelin formulations. Its unique peptide sequence and chemical characteristics make it indispensable for method development, validation, and impurity profiling in both research and industrial settings. The availability of this impurity in a well-characterized form supports advanced chromatographic and spectrometric analyses, facilitating compliance with rigorous quality requirements during drug development and manufacturing processes.
Pharmaceutical Analysis: In the context of pharmaceutical analysis, Leuprorelin (Leuprolide) EP Impurity J serves as a critical reference standard for the identification and quantification of impurities in leuprorelin active pharmaceutical ingredients (APIs) and finished dosage forms. Analytical chemists utilize this impurity to develop and validate high-performance liquid chromatography (HPLC), ultra-high-performance liquid chromatography (UHPLC), and mass spectrometry (MS) methods. By spiking known quantities of Impurity J into sample matrices, researchers can establish accurate calibration curves, determine detection limits, and confirm the specificity and sensitivity of their analytical protocols. This process ensures that the presence of even trace levels of related substances can be reliably detected, supporting robust quality control and regulatory compliance throughout the drug lifecycle.
Stability Studies: During stability studies, the presence and quantification of Leuprorelin (Leuprolide) EP Impurity J provide valuable insights into the degradation pathways of leuprorelin under various storage conditions. Researchers incorporate this impurity into forced degradation experiments to simulate environmental stressors such as heat, light, humidity, and oxidative agents. Monitoring the formation and evolution of Impurity J over time allows scientists to elucidate the mechanisms of peptide degradation, optimize formulation strategies, and establish appropriate shelf-life specifications. The data generated from these studies contribute to the development of stable and effective peptide therapeutics by informing packaging, storage, and handling recommendations.
Process Development: Process chemists and engineers rely on Leuprorelin (Leuprolide) EP Impurity J during the optimization of synthetic and purification processes for leuprorelin manufacturing. By tracking the levels of Impurity J at various stages of synthesis, purification, and formulation, scientists can identify critical process parameters that influence impurity formation. This information guides the refinement of reaction conditions, purification techniques, and in-process controls to minimize impurity content and maximize product yield. The use of Impurity J as a process marker ultimately contributes to the consistency and reproducibility of leuprorelin production at both laboratory and industrial scales.
Reference Standard Qualification: Analytical laboratories utilize Leuprorelin (Leuprolide) EP Impurity J as a benchmark for the qualification of secondary reference standards used in routine quality control testing. By comparing the chromatographic and spectrometric profiles of in-house standards against the well-characterized impurity, laboratories can ensure the accuracy and reliability of their analytical measurements. This practice supports the standardization of testing protocols across different sites and enhances data integrity during regulatory submissions, method transfers, and inter-laboratory studies.
Peptide Research and Characterization: In peptide research, Leuprorelin (Leuprolide) EP Impurity J is an essential tool for exploring the structure-activity relationships, fragmentation patterns, and physicochemical properties of related GnRH analogs. Scientists employ this impurity in mass spectrometry-based studies to investigate peptide fragmentation pathways, validate peptide mapping techniques, and develop novel analytical methodologies. The availability of a well-defined impurity standard accelerates the advancement of peptide science by enabling more precise characterization of synthetic intermediates, degradation products, and process-related impurities.
Leuprorelin (Leuprolide) EP Impurity J thus occupies a pivotal position in the analytical, process development, and research domains associated with peptide therapeutics. Its application as a reference impurity standard underpins the accuracy, sensitivity, and reliability of impurity profiling, stability assessment, and process optimization efforts. Through its integration into pharmaceutical analysis, stability testing, process development, reference standard qualification, and advanced peptide research, this impurity enables scientists to uphold the highest standards of quality and innovation throughout the lifecycle of leuprorelin and related compounds.
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More